Annual Long Term Debt
$5.52 M
-$8.12 M-59.53%
December 31, 2023
Summary
- As of February 12, 2025, ZVRA annual long term debt is $5.52 million, with the most recent change of -$8.12 million (-59.53%) on December 31, 2023.
- During the last 3 years, ZVRA annual long term debt has fallen by -$64.14 million (-92.07%).
- ZVRA annual long term debt is now -93.99% below its all-time high of $91.83 million, reached on December 1, 2016.
Performance
ZVRA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$59.39 M
+$515.00 K+0.87%
September 30, 2024
Summary
- As of February 12, 2025, ZVRA quarterly long term debt is $59.39 million, with the most recent change of +$515.00 thousand (+0.87%) on September 30, 2024.
- Over the past year, ZVRA quarterly long term debt has increased by +$53.87 million (+975.46%).
- ZVRA quarterly long term debt is now -35.69% below its all-time high of $92.34 million, reached on September 1, 2017.
Performance
ZVRA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
ZVRA Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -59.5% | +975.5% |
| 3 y3 years | -92.1% | +975.5% |
| 5 y5 years | -93.0% | +975.5% |
ZVRA Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.5% | +346.0% | at high | +5073.1% |
| 5 y | 5-year | -93.0% | +346.0% | -25.1% | +5073.1% |
| alltime | all time | -94.0% | +5850.4% | -35.7% | +5073.1% |
Zevra Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $59.39 M(+0.9%) |
| Jun 2024 | - | $58.87 M(+34.7%) |
| Mar 2024 | - | $43.70 M(+691.4%) |
| Dec 2023 | $5.52 M(-59.5%) | $5.52 M(-87.6%) |
| Sep 2023 | - | $44.39 M(+232.9%) |
| Jun 2023 | - | $13.34 M(-2.3%) |
| Mar 2023 | - | $13.65 M(+0.1%) |
| Dec 2022 | $13.64 M(+1002.0%) | $13.64 M(-0.8%) |
| Sep 2022 | - | $13.76 M(-0.9%) |
| Jun 2022 | - | $13.88 M(+1109.2%) |
| Mar 2022 | - | $1.15 M(-7.3%) |
| Dec 2021 | $1.24 M(-98.2%) | - |
| Dec 2021 | - | $1.24 M(-7.0%) |
| Sep 2021 | - | $1.33 M(-5.8%) |
| Jun 2021 | - | $1.41 M(-12.3%) |
| Mar 2021 | - | $1.61 M(-97.7%) |
| Dec 2020 | $69.66 M(-12.1%) | $69.66 M(+2713.3%) |
| Sep 2020 | - | $2.48 M(-2.4%) |
| Jun 2020 | - | $2.54 M(+38.1%) |
| Mar 2020 | - | $1.84 M(-97.7%) |
| Dec 2019 | $79.24 M | $79.24 M(+9.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $72.53 M(-6.9%) |
| Jun 2019 | - | $77.88 M(+0.5%) |
| Mar 2019 | - | $77.52 M(-1.3%) |
| Dec 2018 | $78.50 M(-12.7%) | $78.50 M(-10.4%) |
| Sep 2018 | - | $87.62 M(+0.4%) |
| Jun 2018 | - | $87.31 M(-3.3%) |
| Mar 2018 | - | $90.30 M(+0.4%) |
| Dec 2017 | $89.96 M(-2.0%) | $89.96 M(-2.6%) |
| Sep 2017 | - | $92.34 M(+0.4%) |
| Jun 2017 | - | $91.95 M(+0.4%) |
| Mar 2017 | - | $91.56 M(-0.3%) |
| Dec 2016 | $91.83 M(+395.6%) | $91.83 M(+1.2%) |
| Sep 2016 | - | $90.78 M(+0.4%) |
| Jun 2016 | - | $90.39 M(+0.3%) |
| Mar 2016 | - | $90.09 M(+386.2%) |
| Dec 2015 | $18.53 M(+2.3%) | $18.53 M(-3.9%) |
| Sep 2015 | - | $19.27 M(+2.0%) |
| Jun 2015 | - | $18.89 M(+2.1%) |
| Mar 2015 | - | $18.50 M(+2.1%) |
| Dec 2014 | $18.11 M(>+9900.0%) | $18.11 M |
| Dec 2013 | $92.80 K | - |
FAQ
- What is Zevra Therapeutics annual long term debt?
- What is the all time high annual long term debt for Zevra Therapeutics?
- What is Zevra Therapeutics annual long term debt year-on-year change?
- What is Zevra Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Zevra Therapeutics?
- What is Zevra Therapeutics quarterly long term debt year-on-year change?
What is Zevra Therapeutics annual long term debt?
The current annual long term debt of ZVRA is $5.52 M
What is the all time high annual long term debt for Zevra Therapeutics?
Zevra Therapeutics all-time high annual long term debt is $91.83 M
What is Zevra Therapeutics annual long term debt year-on-year change?
Over the past year, ZVRA annual long term debt has changed by -$8.12 M (-59.53%)
What is Zevra Therapeutics quarterly long term debt?
The current quarterly long term debt of ZVRA is $59.39 M
What is the all time high quarterly long term debt for Zevra Therapeutics?
Zevra Therapeutics all-time high quarterly long term debt is $92.34 M
What is Zevra Therapeutics quarterly long term debt year-on-year change?
Over the past year, ZVRA quarterly long term debt has changed by +$53.87 M (+975.46%)